• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 CH 取代噻二唑基硫代酰胺的银(I)配合物对癌细胞增殖和细菌生长的抑制作用。

Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH-Substituted Thiadiazole-Based Thioamide.

机构信息

Laboratory of Inorganic Chemistry, Department of Chemistry, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

Laboratory of Pharmacology, Medical School, National and Kapodistrian University of Athens, 75 Mikras Asias Street, 11527 Athens, Greece.

出版信息

Molecules. 2023 Jan 1;28(1):336. doi: 10.3390/molecules28010336.

DOI:10.3390/molecules28010336
PMID:36615533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9823356/
Abstract

Ag(I) coordination compounds have recently attracted much attention as antiproliferative and antibacterial agents against a wide range of cancer cell lines and pathogens. The bioactivity potential of these complexes depends on their structural characteristics and the nature of their ligands. Herein, we present a series of four Ag(I) coordination compounds bearing as ligands the CH-substituted thiadiazole-based thioamide 5-methyl-1,3,4-thiadiazole-2-thiol (mtdztH) and phosphines, i.e., [AgCl(mtdztH)(PPh)] (), [Ag(mtdzt)(PPh)] (), [AgCl(mtdztH)(xantphos)] (), and [AgmtdztH)(dppe)(NO)] (), where xantphos = 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene and dppe = 1,2-bis(diphenylphosphino)ethane, and the assessment of their in vitro antibacterial and anti-cancer efficiency. Among them, diphosphine-containing compounds and were found to exhibit broad-spectrum antibacterial activity characteristics against both Gram-(+) and Gram-(-) bacterial strains, showing high in vitro bioactivity with IC values as low as 4.6 μΜ. In vitro cytotoxicity studies against human ovarian, pancreatic, lung, and prostate cancer cell lines revealed the strong cytotoxic potential of and , with IC values in the range of 3.1-24.0 μΜ, while and maintained the normal fibroblast cells' viability at relatively higher levels. Assessment of these results, in combination with those obtained for analogous Ag(I) complexes bearing similar heterocyclic thioamides, suggest the pivotal role of the substituent groups of the thioamide heterocyclic ring in the antibacterial and anti-cancer efficacy of the respective Ag(I) complexes. Compounds - exhibited moderate in vitro antioxidant capacity for free radicals scavenging, as well as reasonably strong ability to interact with calf-thymus DNA, suggesting the likely implication of these properties in their bioactivity mechanisms. Complementary insights into the possible mechanism of their anti-cancer activity were provided by molecular docking calculations, exploring their ability to bind to the overexpressed fibroblast growth factor receptor 1 (FGFR1), affecting cancer cells' functionalities.

摘要

Ag(I)配合物作为抗增殖和抗菌剂,对广泛的癌细胞系和病原体具有抗增殖和抗菌作用,最近引起了人们的极大关注。这些配合物的生物活性潜力取决于它们的结构特征和配体的性质。在此,我们介绍了一系列带有取代的噻二唑基硫代酰胺 5-甲基-1,3,4-噻二唑-2-硫醇(mtdztH)和膦配体的四个 Ag(I)配合物,即 [AgCl(mtdztH)(PPh)](),[Ag(mtdzt)(PPh)](),[AgCl(mtdztH)(xantphos)]()和 [AgmtdztH)(dppe)(NO)](),其中 xantphos = 4,5-双(二苯基膦基)-9,9-二甲基氧杂蒽和 dppe = 1,2-双(二苯基膦基)乙烷,并评估了它们的体外抗菌和抗癌效率。其中,含二膦的化合物和对革兰氏阳性和革兰氏阴性细菌菌株均表现出广谱的抗菌活性特征,具有低至 4.6 μΜ 的高体外生物活性。对人卵巢、胰腺、肺和前列腺癌细胞系的体外细胞毒性研究表明,化合物和具有很强的细胞毒性潜力,IC 值范围为 3.1-24.0 μΜ,而化合物和保持相对较高水平的正常成纤维细胞活力。这些结果的评估,结合具有类似杂环硫代酰胺的类似 Ag(I)配合物的结果,表明硫代酰胺杂环的取代基在各自 Ag(I)配合物的抗菌和抗癌功效中起着关键作用。化合物-对自由基具有中等的体外抗氧化能力,具有合理的与小牛胸腺 DNA 相互作用的能力,表明这些特性可能与其生物活性机制有关。通过分子对接计算,对其抗癌活性的可能机制提供了补充见解,探索了它们与过度表达的成纤维细胞生长因子受体 1(FGFR1)结合的能力,从而影响癌细胞的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/60f3a3e9ce18/molecules-28-00336-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/77bd7b369c83/molecules-28-00336-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/4109af43d823/molecules-28-00336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/e717aab26bc4/molecules-28-00336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/0a87fbe3f844/molecules-28-00336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/bece630cbd55/molecules-28-00336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/3bd95dca6f5f/molecules-28-00336-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/b8c401a098f1/molecules-28-00336-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/f67103721497/molecules-28-00336-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/d133f25677b3/molecules-28-00336-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/75e1e692afa4/molecules-28-00336-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/60f3a3e9ce18/molecules-28-00336-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/77bd7b369c83/molecules-28-00336-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/4109af43d823/molecules-28-00336-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/e717aab26bc4/molecules-28-00336-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/0a87fbe3f844/molecules-28-00336-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/bece630cbd55/molecules-28-00336-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/3bd95dca6f5f/molecules-28-00336-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/b8c401a098f1/molecules-28-00336-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/f67103721497/molecules-28-00336-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/d133f25677b3/molecules-28-00336-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/75e1e692afa4/molecules-28-00336-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8152/9823356/60f3a3e9ce18/molecules-28-00336-g010.jpg

相似文献

1
Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH-Substituted Thiadiazole-Based Thioamide.基于 CH 取代噻二唑基硫代酰胺的银(I)配合物对癌细胞增殖和细菌生长的抑制作用。
Molecules. 2023 Jan 1;28(1):336. doi: 10.3390/molecules28010336.
2
Silver(I) complexes bearing heterocyclic thioamide ligands with NH and CF substituents: effect of ligand group substitution on antibacterial and anticancer properties.含 NH 和 CF 取代基的杂环硫代酰胺配体的银(I)配合物:配体基团取代对抗菌和抗癌性能的影响。
Dalton Trans. 2022 Jun 21;51(24):9412-9431. doi: 10.1039/d2dt00793b.
3
Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity - A combined in vitro and in silico study.具有杂环硫代酰胺配体的生物相容的银(I)配合物,用于选择性杀伤癌细胞和高抗菌活性 - 体外和计算研究的结合。
J Inorg Biochem. 2022 Mar;228:111695. doi: 10.1016/j.jinorgbio.2021.111695. Epub 2021 Dec 29.
4
Amine-substituted heterocyclic thioamide Cu(I) and Ag(I) complexes as effective anticancer and antibacterial agents targeting the periplasm of E. coli bacteria.胺取代杂环硫代酰胺 Cu(I)和 Ag(I)配合物作为有效的抗癌和抗菌剂,针对大肠杆菌的周质。
Eur J Med Chem. 2024 Nov 5;277:116746. doi: 10.1016/j.ejmech.2024.116746. Epub 2024 Aug 6.
5
Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: Synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA.含杂环硫代酰胺和三级芳基膦配体的银配合物:合成、晶体结构、体外和计算抗菌和细胞毒性活性以及与 DNA 的相互作用。
J Inorg Biochem. 2020 Sep;210:111167. doi: 10.1016/j.jinorgbio.2020.111167. Epub 2020 Jul 4.
6
Homoleptic and heteroleptic silver(I) complexes bearing diphosphane and thioamide ligands: Synthesis, structures, DNA interactions and antibacterial activity studies.含二膦和硫代酰胺配体的同核和异核银(I)配合物:合成、结构、DNA 相互作用和抗菌活性研究。
Mater Sci Eng C Mater Biol Appl. 2019 Jun;99:450-459. doi: 10.1016/j.msec.2019.01.107. Epub 2019 Jan 25.
7
N-heterocyclic-carbene vs diphosphine auxiliary ligands in thioamidato Cu(I) and Ag(I) complexes towards the development of potent and dual-activity antibacterial and apoptosis-inducing anticancer agents.N-杂环卡宾与二膦配体在硫代酰胺atoCu(I)和Ag(I)配合物中的应用,旨在开发高效且具有双重活性的抗菌和诱导细胞凋亡的抗癌药物。
J Inorg Biochem. 2024 Mar;252:112472. doi: 10.1016/j.jinorgbio.2023.112472. Epub 2023 Dec 23.
8
Structures and biochemical evaluation of silver(I) 5,5-diethylbarbiturate complexes with bis(diphenylphosphino)alkanes as potential antimicrobial and anticancer agents.以双(二苯基膦基)烷烃为配体的巴比妥酸银(I)配合物的结构与生化评价:潜在的抗菌和抗癌剂
Eur J Med Chem. 2017 Oct 20;139:901-916. doi: 10.1016/j.ejmech.2017.08.062. Epub 2017 Aug 31.
9
Di- and polynuclear silver(I) saccharinate complexes of tertiary diphosphane ligands: synthesis, structures, in vitro DNA binding, and antibacterial and anticancer properties.二核和多核银(I)糖精酸盐配合物与叔膦配体:合成、结构、体外 DNA 结合及抗菌和抗癌性能。
J Biol Inorg Chem. 2014 Jan;19(1):29-44. doi: 10.1007/s00775-013-1052-y. Epub 2013 Oct 17.
10
Quinoline Functionalized Schiff Base Silver (I) Complexes: Interactions with Biomolecules and In Vitro Cytotoxicity, Antioxidant and Antimicrobial Activities.喹啉功能化席夫碱银(I)配合物:与生物分子的相互作用及体外细胞毒性、抗氧化和抗菌活性。
Molecules. 2021 Feb 24;26(5):1205. doi: 10.3390/molecules26051205.

本文引用的文献

1
Silver(I) complexes bearing heterocyclic thioamide ligands with NH and CF substituents: effect of ligand group substitution on antibacterial and anticancer properties.含 NH 和 CF 取代基的杂环硫代酰胺配体的银(I)配合物:配体基团取代对抗菌和抗癌性能的影响。
Dalton Trans. 2022 Jun 21;51(24):9412-9431. doi: 10.1039/d2dt00793b.
2
Dinuclear silver and gold bisNHC complexes as drug candidates for cancer therapy.双核银和金双 NHC 配合物作为癌症治疗的候选药物。
Bioorg Med Chem. 2022 Aug 1;67:116814. doi: 10.1016/j.bmc.2022.116814. Epub 2022 May 10.
3
Silver derivatives of multi-donor heterocyclic thioamides as antimicrobial/anticancer agents: unusual bio-activity against methicillin resistant , , and and human bone cancer cell line.
多供体杂环硫代酰胺的银衍生物作为抗菌/抗癌剂:对耐甲氧西林金黄色葡萄球菌、表皮葡萄球菌和人骨肉瘤细胞系具有异常的生物活性。
RSC Adv. 2019 May 17;9(27):15470-15487. doi: 10.1039/c9ra01804b. eCollection 2019 May 14.
4
Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity - A combined in vitro and in silico study.具有杂环硫代酰胺配体的生物相容的银(I)配合物,用于选择性杀伤癌细胞和高抗菌活性 - 体外和计算研究的结合。
J Inorg Biochem. 2022 Mar;228:111695. doi: 10.1016/j.jinorgbio.2021.111695. Epub 2021 Dec 29.
5
Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer.成纤维细胞生长因子受体 1 驱动前列腺癌的转移进展。
Eur Urol Oncol. 2022 Apr;5(2):164-175. doi: 10.1016/j.euo.2021.10.001. Epub 2021 Nov 11.
6
The different interactions of two anticancer drugs with bovine serum albumin based on multi-spectrum method combined with molecular dynamics simulations.基于多谱法结合分子动力学模拟研究两种抗癌药物与牛血清白蛋白的不同相互作用。
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Oct 5;259:119809. doi: 10.1016/j.saa.2021.119809. Epub 2021 May 6.
7
Gold(I) and Silver(I) Complexes with 2-Anilinopyridine-Based Heterocycles as Multitarget Drugs against Colon Cancer.基于 2-苯胺吡啶的杂环的金(I)和银(I)配合物作为针对结肠癌的多靶药物。
Inorg Chem. 2020 Dec 7;59(23):17732-17745. doi: 10.1021/acs.inorgchem.0c02922. Epub 2020 Nov 18.
8
Cytotoxic Properties of 1,3,4-Thiadiazole Derivatives-A Review.1,3,4-噻二唑衍生物的细胞毒性性质综述。
Molecules. 2020 Sep 20;25(18):4309. doi: 10.3390/molecules25184309.
9
Thiadiazole derivatives as anticancer agents.噻二唑衍生物作为抗癌剂。
Pharmacol Rep. 2020 Oct;72(5):1079-1100. doi: 10.1007/s43440-020-00154-7. Epub 2020 Sep 3.
10
Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: Synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA.含杂环硫代酰胺和三级芳基膦配体的银配合物:合成、晶体结构、体外和计算抗菌和细胞毒性活性以及与 DNA 的相互作用。
J Inorg Biochem. 2020 Sep;210:111167. doi: 10.1016/j.jinorgbio.2020.111167. Epub 2020 Jul 4.